Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Molecules (Basel, Switzerland)|February 13, 2025
Effects of Biased Analogues of the Kappa Opioid Receptor Agonist, U50,488, in Preclinical Models of Pain and Side EffectsRoss van de Wetering, Loan Y Vu, Lindsay D Kornberger, et al.ACS Chemical Neuroscience|May 9, 2020
Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Design, Synthesis, and Evaluation of Analogues with Improved Potency and G-protein Activation Bias at the μ-Opioid ReceptorRachel S Crowley, Andrew P Riley, Amy F Alder, et al.Molecules (Basel, Switzerland)|June 28, 2023
The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like BehaviorsRoss van de Wetering, Amy Ewald, Susan Welsh, et al.Molecules (Basel, Switzerland)|October 14, 2018
Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in RodentsBronwyn M Kivell, Kelly F Paton, Nitin Kumar, et al.Journal of Medicinal Chemistry|December 14, 2016
Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Identification of a Potent and Centrally Acting μ Opioid Analgesic with Reduced Abuse LiabilityRachel Saylor Crowley, Andrew P Riley, Alexander M Sherwood, et al.Pharmacology, Biochemistry, and Behavior|January 18, 2022
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disordersJeffrey M Witkin, Arnold Lippa, Jodi L Smith, et al.Journal of Medicinal Chemistry|November 16, 2021
Oxidative Metabolism as a Modulator of Kratom's Biological ActionsSoumen Chakraborty, Rajendra Uprety, Samuel T Slocum, et al.Pageof 4